A wave of marijuana company IPOs and hundreds of thousands of square feet of planned capacity expansion means that the sector will likely be oversupplied in a few years, leading to lower prices for products. Chris Damas, editor of The BCMI Report, explains why he is bearish on the sector on the day another licensed producer — Quebec-based Hydropothecary — makes its debut on the TSX Venture Index.